It is also noteworthy that in patients with newly diagnosed MGMT-unmethylated glioblastoma, personalized neoantigen peptide vaccines induced circulating neoantigen-specific T cell responses and a significant increase in infiltrating CD8+ T cells at relapse only in those who did not receive dexamethasone during vaccine priming (188). This evidence concerns the gene CD8A and glioblastoma.